Natural Capsules Limited — Others, 05-08-2025: Shareholders meeting

Natural Capsules Limited's Annual General Meeting successfully passed all eight resolutions. Shareholders approved the company's annual financial results for the fiscal year ended March 31, 2025. Key approvals included the re-appointment of directors, the continuation of an independent director beyond 75 years, and a revision of the whole-time director's remuneration. Importantly, related party transactions with subsidiary Natural Biogenex Private Limited were sanctioned, with promoter votes excluded from this specific resolution. The appointment of secretarial auditors and commission for non-executive directors also received shareholder approval, indicating strong support for the company's operational and governance frameworks.